Dr. Keith Edward Blackwell, MD

Dr. Blackwell practices at Peter Morton UCLA Medical Building in Los Angeles, California.

Dr. Blackwell's NPI, 1669496964, was assigned on July 27, 2006. Dr. Blackwell graduated from Feinberg School of Medicine in 1988. Dr. Blackwell's California license number on file is G68815.

Dr. Blackwell's primary practice is Peter Morton UCLA Medical Building, at 200 Medical Plz, Los Angeles, CA 90024 in Los Angeles County. The practice phone is (310) 794-9206.

Dr. Blackwell's primary practice is Peter Morton UCLA Medical Building in Los Angeles, California. Dr. Blackwell is also affiliated with Ronald Reagan UCLA Medical Center. The medical group on file is UCLA Head & Neck Associates. Dmand AI also links Dr. Blackwell to 1 more hospital, 2 group practices and clinics, 1 home health agency and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Blackwell practices, 5 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Blackwell's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Blackwell is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dmand AI has Dr. Blackwell's licenses on file in 2 states: California and New York.

Dmand AI lists larynx and vocal cord disease among the conditions Dr. Blackwell treats.

CMS data shows 147 Medicare services from Dr. Blackwell across 3 procedure codes in 2024, for 126 Medicare patients. Medicare paid $15,074 for them. Every service was in an office.

CMS counts 126 Medicare patients who saw Dr. Blackwell in 2024. The largest group is 65 to 74, with 52 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 20% are also on Medicaid. Their average risk score is 1.95, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Blackwell's median patient age at 70, with 41% women.

In 2024, Dr. Blackwell wrote 22 Medicare Part D claims for 15 patients. 77% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $67 in total drug cost. In 2018, CMS named 17 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Dr. Blackwell for performance year 2024, reported as part of a group. Dr. Blackwell accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 7 papers to Dr. Blackwell, published from 2016 to 2021. 2021 was the busiest year, with 2. Dr. Blackwell's most frequent co-authors are Ashley Erin Balaker, MD, Rodrigo Bayon, MD and Steven Bernard Cannady, MD.

CMS Open Payments shows 601 general payments to Dr. Blackwell from 7 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 76% of the total. Stryker Corporation paid the most, $542,877.

Dr. Blackwell graduated from Feinberg School of Medicine in 1988.

Dr. Blackwell is in network with 14 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.